市場調査レポート
商品コード
1439706
整形外科機器 - 世界市場の考察、競合情勢、市場予測(2030年)Orthopedic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
整形外科機器 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の整形外科機器の市場規模は、2023年に440億9,000万米ドル、2030年までに577億9,000万米ドルに達し、2024年~2030年の予測期間にCAGRで4.78%の成長が見込まれます。市場は、65歳以上の人口の増加、変形性関節症や骨粗しょう症などの骨疾患の増加、職業性および非職業性の外傷の増加、医療技術の技術的発展などの要因により収益が増加する見込みであり、予測期間(2024年~2030年)に市場の収益成長が見込まれます。
整形外科機器の市場力学
整形外科機器市場の注目すべき促進要因の1つは、世界の老年人口の増加です。World Population Prospects(2019)のレポートによると、世界の11人に1人が65歳以上であり、その割合は2050年までに世界の6人に1人が65歳以上になります。また、北米や欧州などの地域では、2050年までに4人に1人が65歳以上になると予測されています。老年人口の増加はまた、変形性関節症のようなさまざまな種類の骨障害への道を開き、外科手術やインプラント、長期的な補助に向けた支持療法を必要とします。Organization for Cooperation and Development(2023)によると、年齢が変形性膝関節症と変形性股関節症のもっとも強力な発生要因であり、そこではインプラントがもっとも好まれる機器です。
整形外科機器市場の成長をもたらすもう1つの主な要因は、安全で生体適合性の高いインプラントの製造における継続的な技術の進歩です。例えば、2022年5月、Orthofix US Inc.は複雑な関節手術中の超音波関節再置換システムで使用するOSCAR PROを米国市場と欧州市場で発売しました。このような製品開発活動は、研究開発領域が活発であることを示しており、その結果、改良された製品が市場に投入され、製品の普及に寄与し、ひいては市場成長につながっています。
しかし、代替療法の利用可能性や整形外科機器(特にインプラント)に関連する合併症が、整形外科機器市場の成長抑制要因として作用する可能性があります。
整形外科機器市場は、COVID-19の感染連鎖を断ち切るために必要な措置としてロックダウンが実施されたため、短期間の後退が報告されました。COVID-19パンデミックにより、医療サービスや医療処置の大規模な再編成が行われました。多くの国では、COVID-19危機の間、業務フローを合理化するために、救急医療の必要性に基づいて医療処置を分離し、選択的と見なされるさまざまな医療処置が中断されました。たとえば、Organization for Cooperation and Development(2023)によると、2020年3月、イタリア、アイルランド、ノルウェーなどのほとんどの国々で、人工股関節置換術や人工膝関節置換術の件数が激減しました。ほとんどの国は、COVID-19の状況への対応に注力するため、緊急の場合にのみ外科手術を採用しました。しかし、医療部門を含む産業全体の活動が再開されたことで、整形外科機器市場は活況を呈しています。
整形外科機器市場のセグメント分析
整形外科機器市場の用途セグメントでは、脊椎用整形外科機器カテゴリが予測期間(2024年~2030年)に整形外科機器市場で大きな収益成長を記録する見込みです。これは、職業性外傷や使いすぎによる外傷、転倒、争いによる創傷、スポーツ選手の脊髄損傷などのさまざまな理由で脊髄損傷の症例が増加しているためと考えられます。National Spinal Cord Injury Statistical Centre(2023)によると、2019年に世界で296万6,000人が脊髄損傷とともに生活しており、世界中で毎年1万7,900人が新たに発症しています。このことは、人々に対するより多くの支援機構と効率的な外科手術の必要性をもたらし、より安全で生体適合性の高いインプラントを生涯にわたって人々に提供するよう、整形外科産業を推進します。
当レポートでは、世界の整形外科機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Orthopedic Device Market Type By Product (Implants, Supports, And Others), By Application (Knee Orthopedic Devices, Hip Orthopedic Devices, Wrist Orthopedic Devices, Shoulder Orthopedic Devices, Spine Orthopedic Devices, Ankle Orthopedic Devices, And Others ), By End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centres, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to upsurge in prevalence of ageing population and rise in the cases of bone disorders.
The global orthopedic devices market was valued at USD 44.09 billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2024 to 2030 to reach USD 57.79 billion by 2030. The orthopedic devices market is slated to witness increasing revenue owing to factors such as a growing population of people above the age of 65, a rise in the cases of bone disorders such as osteoarthritis and osteoporosis among others, increasing cases of occupational injuries and non-occupational injuries along with latest technological developments in healthcare technology are further expected to result in the appreciable revenue growth in the orthopedic devices market during the forecast period (2024-2030).
Orthopedic Devices Market Dynamics:
One of the noteworthy drivers of the orthopedic devices market is the rising population of old age people globally. As per the reports from World Population Prospects (2019), one in eleven people in the world are above the age of 65 and their proportion shall increase to one in six people in the world to be aged above 65 years, by the year 2050. The same source also stated that in regions like North America and Europe, it is expected that one in four people shall be above the age of 65 years by the year 2050. The increase in the geriatric population, also paves the way for various types of bone disorders like osteoarthritis, requiring surgical procedures, implants, and support therapies for long-term assistance. According to the Organization for Cooperation and Development (2023), age is the strongest factor for the occurrence of Knee and Hip Osteoarthritis, where implants are the most preferred devices among others.
Another key factor responsible for the growth of the orthopedic devices market is the continuous technological advancements in manufacturing safe and biocompatible implants. For instance, in May 2022, Orthofix US Inc. launched OSCAR PRO for use in ultrasonic arthroplasty revision systems during complex joint surgeries, in the U.S and European markets. Such product development activities indicate an active research and development domain resulting in the launch of improved products in the market, contributing to product uptake and ultimately resulting in market growth.
However, the availability of alternative therapies and complications associated with orthopedic devices, specifically implants, may act as restraining factors to the orthopedic devices market growth.
The orthopedic devices market reported a short period of setback due to the implementation of lockdown as necessary measures to break the chain of the COVID-19 infection transmission. The COVID-19 pandemic resulted in the massive reorganization of healthcare services and the carrying out of medical procedures. Many countries segregated medical procedures based on the need for urgent medical care to streamline the workflow during the COVID-19 crisis and saw various medical procedures considered elective being suspended. For instance, in March 2020, according to the Organization for Cooperation and Development (2023), most countries like Italy, Ireland, and Norway showed a sharp decline in the number of hip and knee replacement surgeries. Most countries adopted surgical procedures only in cases of immediate urgency to focus more on handling the COVID-19 situation. However, with the resumption of activities across industries including the healthcare sector, it has been uplifting the orthopedic devices market.
Orthopedic Devices Market Segment Analysis:
Orthopedic devices Market Type by Product (Implants, Supports, and others), Application (Knee Orthopedic Devices, Hip Orthopedic Devices, Wrist Orthopedic Devices, Shoulder Orthopedic Devices, Spine Orthopedic Devices, Ankle Orthopedic Devices, and Others), End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centres and others), Geography (North-America, Europe, Asia-Pacific, Rest of the World)
Based on the application segment of the orthopedic devices market the spinal orthopedic devices category is projected to register significant growth in revenue in the orthopedic devices market during the forecast period (2024-2030). This can be ascribed to the rising cases of spinal cord injuries for various reasons such as occupational work, overuse injuries, falls, wounds from fights, spinal injuries to athletes, etc. According to the National Spinal Cord Injury Statistical Centre (2023) in the year 2019, 2,96,000 people were living with spinal cord injuries globally, with 17,900 new cases happening every year around the world. This brings the need for more assistance support mechanisms and efficient surgical procedures for people, which drives orthopedic industries to deliver safer, biocompatible implants for people on a lifetime basis.
Therefore, considering the growing demand for this product type, numerous new products are being launched in the market. For instance, in October 2020, Stryker Corporation introduced Niagra Lateral Access System for spinal injuries and deformities, after the completion of successful 600 surgeries. The implant is widely compatible with patients, allowing fewer chances of contamination and side effects, with a biocompatible titanium. Therefore, considering the advantages associated with spinal reconstruction devices and their growing popularity among end-users, this product segment is expected to generate considerable revenue thereby pushing the overall growth of the global orthopedic devices market during the forecast period.
North America is expected to dominate the overall Orthopedic Devices Market:
Among all the regions, North America is expected to lead in revenue generation in the global orthopedic devices market. This can be ascribed to the growing population of old-aged people in the region. For instance, according to the U.S. Census Bureau (2023), the old age population observed an increase of 34.2%, from 40.3 million U.S. residents aged 65 years in the year 2010 to 54.1 million or older in the year 2019.
One of the prominent factors supporting the growth of the North America orthopedic devices market is the rising prevalence of bone disorders like osteoarthritis, osteoporosis, etc. For example, as per the CDC report (2023), more than 32.5 million people are affected by Osteoarthritis which is one of the most common forms of joint disorders in the United States. Along with the growing aged population, the risk of bone disorders also increases. For instance, according to the Osteoarthritis Action Alliance (2023), in the year 2019, 43% of people aged above 65 years and 88% of people aged above 45 years were diagnosed with Osteoarthritis. The source further stated that more than 60% of people affected were women. Considering the rising number of bone disorders in the country, numerous products are receiving regulatory approvals thus paving the way for their market launch. For instance, in May 2022, the U.S. Food and Drug Administration (FDA) approved the AccelStim Bone growth Stimulator, manufactured by Orthofix US LLC, which can be used in cases of bone fractures. Also, In September 2020, Stryker Corporation launched its titanium-made AxSOS Ankle Fusion System for the tibiotalar joint with updated screw offerings.
Therefore, the presence of a large patient base coupled with increasing cases of bone disorders drives manufacturers to launch new products, which is expected to drive the growth of the orthopedic devices market in the United States during the forecast period.
In addition to the rising old age population and cases of bone disorders, there has been an increase in the number of occupational injuries and non-occupational injuries in the United States. For example, according to the U.S Bureau of Labor Statistics (2023), an incidence rate of 25.4% of occupational injuries was observed of which 24% of injuries consisted of traumatic injuries in the year 2020. The source also stated that there were about 53,000 cases of injuries to the bone, cartilage, and tendons along with sprains, strains, and muscle tears, resulting from non-occupational reasons such as violence, abuse, and fights requiring implants and other assistance mechanisms. Therefore, such reasons coupled with a large patient pool having bone disorders and occupational injuries shall further drive the demand for orthopedic devices in the United States during the forecast period.
Orthopedic Devices Market Key Players:
Some of the key market players operating in the orthopedic devices market include Stryker Corporation, Zimmer Biomet, Johnson and Johnson, Enovis, Smith & Nephew PLC, Medtronic PLC, Boston Scientific Corporation, NuVasive Inc., Globus Medical Inc., ConMed Corporation, Bioventus, Orthofix, Colson Medical LLC, Exactech Inc., Medacta International, Surgalign Holdings, Paragon 28 Inc, Orthofix, Arthrex Inc., Seimens, Bosch Global, and others.
Recent Developmental Activities in the Orthopedic Devices Market:
In May 2022, Orthofix US LLC got approval from the FDA for its orthopedic device AccelStim Bone Growth Stimulator in Texas, USA, which can be used in cases of bone fractures.
In March 2022, Stryker launched the Insignia Hip stem, used for total hip stem arthroplasty and hemi-arthroplasty processes, at the American Academy of Orthopedic Surgeons Annual Meeting.
In June 2022, Medtronic received FDA clearance for UNiD rods, screws, and fusion devices that uses Artificial Intelligence Technology for treating spinal injuries.
Key Takeaways from the Orthopedic Devices Market Report Study
Target Audience who can be benefited from this Orthopedic Devices Market Report Study
Frequently Asked Questions for Orthopedic Devices Market:
Orthopedic devices can be defined as any device, physical support, or implant assisting the human body, mostly in the skeletal system to restore damaged bones, joints, ligaments, and other neighboring structures to recover primary functional locomotive abilities.
The global orthopedic devices market was valued at USD 44.09 billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2024 to 2030 to reach USD 57.79 billion by 2030.
The orthopedic device market is expected to grow significantly owing to factors such as the growing prevalence of bone diseases such as osteoarthritis, osteoporosis, etc. The global rise in the old age population also will lead to an increase in the number of assistance and support devices in the future. Increasing cases of occupational injuries and road accidents are further expected to result in appreciable revenue growth in the orthopedic device market during the forecast period (2024-2030).
Some of the key market players operating in the orthopedic devices market include Stryker Corporation, Zimmer Biomet, Johnson and Johnson, Enovis, Smith & Nephew PLC, Medtronic PLC, Boston Scientific Corporation, NuVasive Inc., Globus Medical Inc., ConMed Corporation, Bioventus, Orthofix, Colson Medical LLC, Exactech Inc., Medacta International, Surgalign Holdings, Paragon 28 Inc, Orthofix, Arthrex Inc., Integra Lifesciences, Bosch Global, and others.
North America is expected to dominate the overall Orthopedic device market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a large old age population in the North American region. Increasing cases of bone disorders like osteoarthritis and osteoporosis and weak skeletal system also do play a major role in driving the orthopedic device market in the region. In addition, it is a highly potent market in terms of product development and launches, and the presence of key market players also driving the market growth.